NOV 2014 ARTICLE LIST >>
PharmaTutor (November- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 11)
Received On: 16/09/2014; Accepted On: 28/09/2014; Published On: 01/11/2014
AUTHORS: V. Sujatha*, T. Vishnuvaravidyadhar, M.Parvathi, Suryaprakash Reddy
*Department of Pharmaceutics,
Raghavendra Institute of Pharmaceutical Education & Research,
RIPERK R Palli Cross, Near S.K University, Anantapuramu District, Andhra Pradesh, India
valmiki.sujatha@gmail.com
ABSTRACT:
Transdermal drug delivery system is one type of more convenient drug delivery system. Skin acts a barrier for transdermal through drug delivery system. Drug across through stratum corneum by low diffusion process. Drug formulation with elastic vesicle or skin enhances vesicles. Etho sources are the ethanolic phospholipids vesicles and which are having higher rate of penetration through the skin. The purpose of writing this Review on ethosome drug focus on the Ethosomes including their mechanism of penetration. Transdermal drug delivery system was came into existence by more than 30 years ago. Ethosomes are the ethanolic phospholipid vesicles. These are used mainly for transdermal delivery of drugs. Ethosomes have higher penetration rate through the skin as compared to liposomes hence these can be used widely in place of liposomes. Ethosomes enhanced skin permeation, improved drug delivery, increased drug entrapment efficiency etc.
How to cite this article: V Sujatha, TVV Vidyadhar, M Parvathi, S Reddy; A Review on Transdermal Drug Delivery System by Ethosomes; PharmaTutor; 2014; 2(11); 50-55
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Hadgraft J, Walters K A, Guy R H; Epidermal Lipids and Topical Drug Delivery. Dermatology. 1992; 11:139-144.
2. Dayan N, Touitou E. Carriers for skin delivery of triexphenidylHCl: Ethosome Vs Lipsomes. Biomaterials 2000;21 : 1879 – 1885.
3. New R C. Preparation of liposomes and size determination, In:Liposomes A Practical
4. Touitou E. Composition of applying active substance to or through the skin. US
5. Flynn G L; In Principles of route-to-route extrapolation for risk assessment. Gerrity T R, Henry C J. Eds. Elsevier Science Publishing Co. Inc. New York, 1990; 93-127.
6. Gangwar S, Singh S, Garg G, “Ethosomes: A novel tool for drug delivery through the skin”, Journal of Pharmacy Research 2010, 3 (4), 688-691.
7. Heeremans JLM, Gerristen HR, Meusen SP, Mijnheer FW, Gangaram RS, Panday G, Prevost R, Kluft C, Crommelin DJA, “The preparation of tissue typeplasminogen activator (t- PA) containing liposomes
8. Touitou E. Drug delivery across skin. Expert Opinion on Biological Therapy 2002; 2: 723
9. Dinesh D, Amit AR, Maria S, Awaroop R L, Mohd HGD, “Drug vehicle based approaches of penetration enhancement”, Int. J. Pharm. Pharm. Sci., 2009, 1 (1), 24-45.
10. Cevc G, Schatzlein A, Blume G. Transdermal drug carriers: Basic properties, optimization and transfer efficiency in case of epicutaneously applied peptides. J. Cont. Release 1995;36: 316.
11. Maghraby G.M, Williams A.C, Barry B.W. Oestradiol skin delivery from ultra deformableliposomes: refinement of surfactant concentration. Int. J. Pharma. 2000: 63-74.
12. Berge V, Swartzendruber V.B, Geest J. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J. Microscopy 1997;187(2): 125-133.
13. Kumar KP, Radhika PR, Sivakumar T, “Ethosomes-A Priority in Transdermal Drug Delivery”, International Journal of Advances in Pharmaceutical Sciences, 2010, 1, 111-121.
14. Touitou E. Composition of applying active substance to or through the skin. USPatent:5716638, 1996.
15. Touitou E, Composition of applying active substance to or through the skin. US Patent:5540934, 1998.
16. Jain S, Umamaheshwari R.B, Bhadra D, Jain N.K, Ethosomes: a novel vesicular carrier forenhanced transdermal delivery of an anti-HIV agent. Ind. J. Pharm. Sci. 2004;66 : 72-81.
17. Verma D D, Fahr A. Synergistic penetration effect of ethanol and phospholipids on the topical delivery of Cyclosporin. J. Cont.Release 2004;97: 55-66.
18. Michaels A S, Chandeasekaran S K, Shaw J E; Drug permeation through human skin: Theory and in-vitro experimental measurement. Am InstChemEng J. 1975; 21: 985-996.
19. Flynn G L, Durrheim H, Higuchi I W; Permeation of hairless mouse skin II: Membrane sectioning techniques and influence on alkanolpermeabilitie. J Pharm Sci. 1981; 70:2-56
20. Touitou E. Composition of applying active substance to or through the skin., US patent,5,540,934, 1998.
21. Dayan N, Touitou E; Carrier for skin delivery of trihexyphenidylHCl: Ethosomes vs liposomes. Biomaterials. 2002; 21:1879-1885
22. Patent:5716638, 1996.Gangwar S, Singh S, Garg G, “Ethosomes: A novel tool for drug delivery through the skin”, Journal of Pharmacy Research 2010, 3 (4), 688-691
23. Kumar KP, Radhika PR, Sivakumar T, “Ethosomes-A Priority in Transdermal Drug Delivery”, International Journal of Advances in Pharmaceutical Sciences, 2010, 1, 111-121.
24. Approach, New RRC (Ed.), Oxford University Press, Oxford. 1990; 36-3.
25. Fry D W, White J C, Goldman I D; Rapid secretion of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978; 90:809-815.
26. Touitou E, Dayan N, Bergelson L, Godin B and Eliaz M, (2000). Ethosomes-novel vesicular carriers for enhances. Upadhyay N et al./Rec Res Sci Tech 3 (2011) 19-24 delivery: characterization and skin penetration properties. J. Control. Release; 65:403-418
27. Bhalaria M K, Naik A N, MisraA N; Ethosomes: a novel delivery system for antifungal drug in the treatment of topical fungal disease. Indian journal of expiermental biology. 2009; 47: 368 375.
28. Verma, DD and Fahr A, (2004). Synergistic penetrations effect of ethanol and phospholipids on the topical delivery of CyclosporinA, J. Control Release, 97: 55-66.
29. Nikalje AP, Tiwari S, “Ethosomes: A Novel Tool for Transdermal Drug Delivery”, IJRPS, 2012, 2 (1), 1-20.
30. Schreier H, Bovwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. Journal of Control Release 1994; 30: 1 – 15.
.png)
